Oral estramustine and oral etoposide for hormone-refractory prostate cancer.
Dimopoulos MA, Panopoulos C, Bamia C, Deliveliotis C, Alivizatos G, Pantazopoulos D, Constantinidis C, Kostakopoulos A, Kastriotis I, Zervas A, Aravantinos G, Dimopoulos C.
Dimopoulos MA, et al. Among authors: bamia c.
Urology. 1997 Nov;50(5):754-8. doi: 10.1016/S0090-4295(97)00323-3.
Urology. 1997.
PMID: 9372887
Clinical Trial.